Aureus
FRed Flag

Eli Lilly and Company(LLY)

F

Financial data as of Dec 31, 2025Declining · Healthcare

FCF Margin9.2%Free Cash Flow / Revenue
Cash Conversion81.5%Operating CF / Net Income
Free Cash Flow$6.0B
Revenue$65.2B
Net Cash-$35.2BNet debt position
Debt / FCF7.1xElevated debt burden
Current Ratio1.58Adequate short-term liquidity
YoY FCF Growth-65.0%4 of 5 quarters positive

How This Grade Was Calculated

Base grade from FCF margin, adjusted by financial health factors

BaseC
→
-1High debt-to-FCF ratio (7.1x)
→
-1Significant YoY FCF decline (-65.0%)
→
-0.5Highly volatile FCF (consistency: 1.90)
→
FinalF

Analysis Summary

Concerns

  • Low FCF margin (9.2%)
  • Heavy debt position ($35.2B net debt, 7.1x FCF)
  • High debt-to-FCF ratio (7.1x)
  • Significant YoY FCF decline (-65.0%)
  • Highly volatile quarterly FCF

Financial Breakdown

Key financials compared side by side

Margin Composition

FCF Margin9.2%
Net Margin31.7%
Operating CF Margin25.8%
CapEx Ratio16.6%

Balance Sheet Health

Debt, liquidity, and leverage snapshot

Net Cash-$35.2BNet debt position
Debt / FCF7.1xElevated debt burden
Current Ratio1.58Strong liquidity
Debt / Equity1.60Moderate leverage

Quarterly FCF Trend

-65.0% YoYDeclining (-65.0%)

Free cash flow per quarter

Sector Comparison — Healthcare

FCF Margin ranked against sector peers

View all →

Detailed Metrics

Company NameEli Lilly and Company
SectorHealthcare
Free Cash Flow$6.0B
Revenue$65.2B
Net Income$20.6B
Operating Cash Flow$16.8B
Capital Expenditure$10.8B
FCF Margin9.2%
Cash Conversion Rate81.5%
Net Margin31.7%
Total Debt$42.5B
Total Cash$7.3B
Net Cash-$35.2B
Current Ratio1.58
Debt / Equity1.60
Debt / FCF7.1x
YoY FCF Growth-65.0%
Positive Quarters4 of 5
Trend DirectionDeclining
Report DateDec 31, 2025
GradeF
Data SourceYahoo Finance